AdvanCell Pty Ltd, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, has appointed Philina Lee, PhD as Chief Executive Officer and member of the Board of Directors. Lee will head AdvanCell’s U.S. expansion, accelerating clinical, manufacturing, and partnership activities to advance lead clinical candidate 212Pb-ADVC001 and the company’s radiopharmaceutical portfolio. She will assume her role from January 1, 2026, and will be based at the c...